Last reviewed · How we verify
VC004 and Itraconazole — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
VC004 and Itraconazole (VC004 and Itraconazole) — Jiangsu vcare pharmaceutical technology co., LTD.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| VC004 and Itraconazole TARGET | VC004 and Itraconazole | Jiangsu vcare pharmaceutical technology co., LTD | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- VC004 and Itraconazole CI watch — RSS
- VC004 and Itraconazole CI watch — Atom
- VC004 and Itraconazole CI watch — JSON
- VC004 and Itraconazole alone — RSS
Cite this brief
Drug Landscape (2026). VC004 and Itraconazole — Competitive Intelligence Brief. https://druglandscape.com/ci/vc004-and-itraconazole. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab